Premium accounts now available! Sign up and create a premium account. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Image

[Articles] Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial

Journal content Created on 08 Jun 2026 The Lancet

Michelle Welch, Thomas Forst, Weiping Jia, Pedro Orozco del Pino, Max Denning, Wen-Shuo Wu, Jianghao Li, Rong Liu, Michele Eifu, Yanyun Chen, ACHIEVE-2 Trial Investigators

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 45
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement